YAR SAĞLAM, A. S. Et Al. 2016. HDAC INHIBITORS, MS-275 AND SALERMIDE, POTENTIATES THE ANTICANCER EFFECT OF EF24 IN HUMAN PANCREATIC CANCER CELLS. EXCLI JOURNAL , vol.15 , 246-255.

YAR SAĞLAM, A. S., Yilmaz, A., ÖNEN, H. İ., Alp, E., KAYHAN, H., & Ekmekci, A., (2016). HDAC INHIBITORS, MS-275 AND SALERMIDE, POTENTIATES THE ANTICANCER EFFECT OF EF24 IN HUMAN PANCREATIC CANCER CELLS. EXCLI JOURNAL , vol.15, 246-255.

YAR SAĞLAM, ATİYE Et Al. "HDAC INHIBITORS, MS-275 AND SALERMIDE, POTENTIATES THE ANTICANCER EFFECT OF EF24 IN HUMAN PANCREATIC CANCER CELLS," EXCLI JOURNAL , vol.15, 246-255, 2016

YAR SAĞLAM, ATİYE S. Et Al. "HDAC INHIBITORS, MS-275 AND SALERMIDE, POTENTIATES THE ANTICANCER EFFECT OF EF24 IN HUMAN PANCREATIC CANCER CELLS." EXCLI JOURNAL , vol.15, pp.246-255, 2016

YAR SAĞLAM, A. S. Et Al. (2016) . "HDAC INHIBITORS, MS-275 AND SALERMIDE, POTENTIATES THE ANTICANCER EFFECT OF EF24 IN HUMAN PANCREATIC CANCER CELLS." EXCLI JOURNAL , vol.15, pp.246-255.

@article{article, author={ATİYE SEDA YAR SAĞLAM Et Al. }, title={HDAC INHIBITORS, MS-275 AND SALERMIDE, POTENTIATES THE ANTICANCER EFFECT OF EF24 IN HUMAN PANCREATIC CANCER CELLS}, journal={EXCLI JOURNAL}, year=2016, pages={246-255} }